SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

Pediatric dermatologists reported they are not fairly compensated for educating primary care residents and struggle to ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

The Ethics and Public Policy Center report on mifepristone has earned headlines on the right, but what does the data show?

Halberd Corporation (OTC: HALB) in cooperation with Athena Telemedicine Partners, LLC, announces astounding clinical efficacy ...

Researchers at the Indiana University Indianapolis Fairbanks School of Public Health have released updated findings that ...

An unsound study alleging that white doctors are responsible for worse clinical outcomes with black newborns because of “spontaneous bias” ...

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

A University of Maine study has compared how well artificial intelligence models and human clinicians handled complex or ...

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.